Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Response Letter
.
Show all posts
Showing posts with label
Response Letter
.
Show all posts
Tuesday, March 12, 2019
Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application
›
In continuation f my update on ALKS 5461 Alkermes plc (Nasdaq: ALKS) announced that it received a Complete Response Letter ...
›
Home
View web version
